Determination of kidney function before tenofovir initiation: four-fold difference in need of tenofovir dose reduction depending on method used [letter]

J van Griensven; T Sopheak; O Koole; GA Verpooten; L Lynen

doi:10.1097/QAI.0b013e3182199f00

Determination of kidney function before tenofovir initiation: four-fold difference in need of tenofovir dose reduction depending on method used [letter]

J van Griensven, T Sopheak, O Koole, GA Verpooten, L Lynen

Research output: Contribution to journal › Letter › peer-review

Original language	English
Journal	Journal of Acquired Immune Deficiency Syndromes
Volume	57
Issue number	2
Pages (from-to)	e21-e23
Number of pages	3
ISSN	1525-4135
DOIs	https://doi.org/10.1097/QAI.0b013e3182199f00
Publication status	Published - 2011

Keywords

B780-tropical-medicine
Viral diseases
HIV
AIDS
HAART
Antiretrovirals
Tenofovir
Dosage
Methods
Safety
Effectiveness
Kidney function
World Health Organization (WHO)
WHO
Guidelines
Recommendations
Cambodia
Asia-Southeast

Access to Document

10.1097/QAI.0b013e3182199f00

http://lib.itg.be/pdf/itg/2011/2011jaid0e21.pdf

Cite this

@article{30d295c762ef41e88a95b9db9ac0e9ae,

title = "Determination of kidney function before tenofovir initiation: four-fold difference in need of tenofovir dose reduction depending on method used [letter]",

keywords = "B780-tropical-medicine, Viral diseases, HIV, AIDS, HAART, Antiretrovirals, Tenofovir, Dosage, Methods, Safety, Effectiveness, Kidney function, World Health Organization (WHO), WHO, Guidelines, Recommendations, Cambodia, Asia-Southeast",

author = "{van Griensven}, J and T Sopheak and O Koole and GA Verpooten and L Lynen",

note = "NPP; ITG-C1A; ITG-C3B; ITG-CLA; CLINIC; U-HIVCLI; JIF; DOI; PDF; DSPACE",

year = "2011",

doi = "10.1097/QAI.0b013e3182199f00",

language = "English",

volume = "57",

pages = "e21--e23",

journal = "Journal of Acquired Immune Deficiency Syndromes",

issn = "1525-4135",

publisher = "Lippincott Williams & Wilkins",

number = "2",

}

TY - JOUR

T1 - Determination of kidney function before tenofovir initiation: four-fold difference in need of tenofovir dose reduction depending on method used [letter]

AU - van Griensven, J

AU - Sopheak, T

AU - Koole, O

AU - Verpooten, GA

AU - Lynen, L

N1 - NPP; ITG-C1A; ITG-C3B; ITG-CLA; CLINIC; U-HIVCLI; JIF; DOI; PDF; DSPACE

PY - 2011

Y1 - 2011

KW - B780-tropical-medicine

KW - Viral diseases

KW - HIV

KW - AIDS

KW - HAART

KW - Antiretrovirals

KW - Tenofovir

KW - Dosage

KW - Methods

KW - Safety

KW - Effectiveness

KW - Kidney function

KW - World Health Organization (WHO)

KW - WHO

KW - Guidelines

KW - Recommendations

KW - Cambodia

KW - Asia-Southeast

U2 - 10.1097/QAI.0b013e3182199f00

DO - 10.1097/QAI.0b013e3182199f00

M3 - Letter

C2 - 21709448

SN - 1525-4135

VL - 57

SP - e21-e23

JO - Journal of Acquired Immune Deficiency Syndromes

JF - Journal of Acquired Immune Deficiency Syndromes

IS - 2

ER -